We are live on
!
Find out more
CIC
Carnegie Investment Counsel Portfolio holdings
AUM
$4.99B
1-Year Est. Return
23.08%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$1.54B
AUM Growth
+$81.9M
(+5.6%)
Cap. Flow
+$25.9M
Cap. Flow
% of AUM
1.69%
Top 10 Holdings %
Top 10 Hldgs %
19.93%
Holding
435
New
22
Increased
147
Reduced
184
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$4.9M |
| 2 |
Walt Disney
DIS
|
+$3.71M |
| 3 |
Adobe
ADBE
|
+$3.68M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$3.35M |
| 5 |
Chevron
CVX
|
+$2.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$4.12M |
| 2 |
Wells Fargo
WFC
|
+$3.08M |
| 3 |
XYZ
Block Inc
XYZ
|
+$2.83M |
| 4 |
AABA
Altaba Inc
AABA
|
+$2.12M |
| 5 |
Northrop Grumman
NOC
|
+$2.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.5% |
| 2 | Technology | 12.42% |
| 3 | Industrials | 12.07% |
| 4 | Healthcare | 9.17% |
| 5 | Consumer Discretionary | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Annaly Capital Management
NLY
$17.5B
| $1.14M | 0.07% |
31,066
+10,263
| +49% | +$391K |
|
202
Novartis
NVS
$295B
| $1.13M | 0.07% |
12,349
-1,675
| -12% | -$142K |
|
203
Paychex
PAYX
$43.2B
| $1.12M | 0.07% |
13,651
-295
| -2% | -$24.9K |
|
|
IBMH
204
DELISTED
iShares iBonds Sep 2019 Term Muni Bond ETF
IBMH
| $1.12M | 0.07% |
44,025
| – | – |
|
205
Duke Energy
DUK
$95.7B
| $1.12M | 0.07% |
12,669
-471
| -4% | -$41.6K |
|
|
DFS
206
DELISTED
Discover Financial Services
DFS
| $1.1M | 0.07% |
14,202
-750
| -5% | -$58.1K |
|
207
Chipotle Mexican Grill
CMG
$40.4B
| $1.09M | 0.07% |
74,450
-10,000
| -12% | -$141K |
|
208
M&T Bank
MTB
$36.5B
| $1.09M | 0.07% |
6,414
-275
| -4% | -$45.6K |
|
209
CRISPR Therapeutics
CRSP
$5.16B
| $1.06M | 0.07% |
+22,600
| New | +$903K |
|
210
Hasbro
HAS
$13.8B
| $1.04M | 0.07% |
9,837
-43
| -0.4% | -$4.24K |
|
211
AbbVie
ABBV
$439B
| $1.02M | 0.07% |
14,045
-665
| -5% | -$52.3K |
|
212
Starwood Property Trust
STWD
$6.22B
| $1.01M | 0.07% |
44,550
| – | – |
|
|
STOR
213
DELISTED
STORE Capital Corporation
STOR
| $1.01M | 0.07% |
30,488
-100
| -0.3% | -$3.38K |
|
214
IBM
IBM
$224B
| $1M | 0.07% |
7,612
-929
| -11% | -$122K |
|
215
Editas Medicine
EDIT
$455M
| $989K | 0.06% |
+39,990
| New | +$955K |
|
216
General Mills
GIS
$20.1B
| $983K | 0.06% |
18,715
| – | – |
|
217
Goldman Sachs
GS
$303B
| $982K | 0.06% |
4,801
-1,774
| -27% | -$351K |
|
218
Intellia Therapeutics
NTLA
$1.67B
| $982K | 0.06% |
+60,000
| New | +$943K |
|
219
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $972K | 0.06% |
12,065
-3,805
| -24% | -$303K |
|
220
iShares US Medical Devices ETF
IHI
$3.47B
| $962K | 0.06% |
23,988
-24
| -0.1% | -$908 |
|
221
Teladoc Health
TDOC
$1.25B
| $955K | 0.06% |
14,380
-18,900
| -57% | -$1.1M |
|
222
Altria Group
MO
$109B
| $940K | 0.06% |
19,843
-59
| -0.3% | -$3.09K |
|
223
BP
BP
$111B
| $937K | 0.06% |
22,857
-745
| -3% | -$31.3K |
|
224
MetLife
MET
$61.5B
| $918K | 0.06% |
18,474
-396
| -2% | -$18.6K |
|
225
Hexcel
HXL
$7.65B
| $914K | 0.06% |
11,305
-700
| -6% | -$50.9K |
|
Similar funds
MA
SNT
AM
SGM
PAMP
BCM
NL
O
Carnegie Investment Counsel's Q2 2019 Portfolio in Review
As of Q2 2019, Carnegie Investment Counsel held 435 positions worth $1.54B, up 5.6% from $1.46B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Carnegie Investment Counsel's Q2 2019 filing shows 22 new, 147 increased, 184 reduced and 13 closed positions. Its largest new stake was Dow Inc: 46,030 shares worth $2.27M. The largest sale was DuPont de Nemours, an estimated $4.12M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.
- Carnegie Investment Counsel's largest Q2 2019 buy was Dow Inc: 46,030 shares worth $2.27M.
- Carnegie Investment Counsel added most to Progressive in Q2 2019, an estimated $4.9M increase.
- Carnegie Investment Counsel's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $4.12M.
- Carnegie Investment Counsel fully exited Altaba Inc in Q2 2019, selling an estimated $2.12M.
- Carnegie Investment Counsel's ten largest holdings make up 20% of its $1.54B portfolio in Q2 2019.
- Carnegie Investment Counsel opened 22 new positions and closed 13 in Q2 2019.
- Carnegie Investment Counsel's portfolio value rose 5.6% quarter-over-quarter to $1.54B.
Based on Carnegie Investment Counsel's 13F filing for Q2 2019, filed 24 Jul 2019.